Induction of anti-aging gene klotho with a small chemical compound that demethylates CpG islands

Dongju Jung1,2, Yuechi Xu1, Zhongjie Sun1

  • 1Department of Physiology, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Oncotarget
|June 29, 2017
PubMed

Insights

A novel compound, N-(2-chlorophenyl)-1H-indole-3-caboxamide (Compound H), induces the anti-aging Klotho (KL) gene by demethylating its DNA. This epigenetic modification enhances transcription factor binding, offering potential therapeutic strategies for age-related diseases.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Gerontology

Background:

  • Klotho (KL) is an anti-aging gene, with mutations causing premature aging phenotypes in mice.
  • Increased KL expression shows promise for treating age-related diseases like arteriosclerosis and diabetes.
  • Mechanisms for inducing KL expression remain largely unknown.

Purpose of the Study:

  • To elucidate the molecular mechanism by which Compound H induces Klotho (KL) gene expression.
  • To investigate the role of epigenetic modifications in Compound H-mediated KL induction.

Main Methods:

  • High-throughput screening identified N-(2-chlorophenyl)-1H-indole-3-caboxamide (Compound H) as a KL inducer.
  • Investigated Compound H's effect on KL gene methylation status.
  • Assessed the impact of Compound H on demethylase activity and transcription factor binding (Pax4, Kid3) to the KL promoter.

Main Results:

  • Compound H increased KL expression through demethylation of CpG islands in the KL gene.
  • Demethylation was mediated by activating demethylases, not inhibiting methylases.
  • Compound H enhanced transcription factor binding (Pax4, Kid3) to the KL promoter, influencing its activity.

Conclusions:

  • Demethylation is a key molecular mechanism for Compound H-induced KL expression.
  • Compound H's epigenetic action on the KL gene presents a novel therapeutic avenue.
  • Further in vivo studies are needed to evaluate Compound H's therapeutic potential for age-related diseases.

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.0K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.0K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.2K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
7.8K